Segment Information (Tables)
|
6 Months Ended |
Jun. 30, 2021 |
Segment Reporting [Abstract] |
|
Schedule of reportable business segment information |
Reportable business segment information is as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Net sales: |
|
|
|
|
|
|
|
Asia |
$ |
43,536 |
|
|
$ |
32,757 |
|
|
$ |
79,291 |
|
|
$ |
63,715 |
|
Europe |
21,455 |
|
|
15,465 |
|
|
43,655 |
|
|
36,092 |
|
North America |
37,372 |
|
|
34,471 |
|
|
75,134 |
|
|
73,228 |
|
Latin America and Other |
6,615 |
|
|
4,593 |
|
|
13,319 |
|
|
10,177 |
|
Total net sales |
108,978 |
|
|
87,286 |
|
|
211,399 |
|
|
183,212 |
|
|
|
|
|
|
|
|
|
Contribution margin (1): |
|
|
|
|
|
|
|
Asia |
18,463 |
|
|
16,052 |
|
|
33,782 |
|
|
30,579 |
|
Europe |
6,588 |
|
|
5,202 |
|
|
13,384 |
|
|
12,033 |
|
North America |
16,259 |
|
|
11,904 |
|
|
31,699 |
|
|
26,323 |
|
Latin America and Other |
3,762 |
|
|
1,946 |
|
|
7,394 |
|
|
4,396 |
|
Total contribution margin |
45,072 |
|
|
35,104 |
|
|
86,259 |
|
|
73,331 |
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses (2) |
35,586 |
|
|
28,504 |
|
|
69,138 |
|
|
59,569 |
|
Operating income |
9,486 |
|
|
6,600 |
|
|
17,121 |
|
|
13,762 |
|
|
|
|
|
|
|
|
|
Other income (loss), net |
529 |
|
|
1,509 |
|
|
(1,404) |
|
|
(901) |
|
Income before provision for income taxes |
$ |
10,015 |
|
|
$ |
8,109 |
|
|
$ |
15,717 |
|
|
$ |
12,861 |
|
_________________________________________
(1) Contribution margin consists of net sales less cost of sales and volume incentives expense.
(2) Service fees in China totaled $3.7 million and $6.5 million for the three and six-month periods ended June 30, 2021, respectively, compared to $2.9 million and $4.8 million for the three and six-month periods ended June 30, 2020. These service fees are included in selling, general and administrative expenses.
|
Schedule of consolidated net sales revenue by geographical locations |
From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three and six-month periods ended June 30, 2021 and 2020, as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Net sales: |
|
|
|
|
|
|
|
United States |
$ |
34,378 |
|
|
$ |
32,147 |
|
|
$ |
69,298 |
|
|
$ |
67,986 |
|
South Korea |
17,546 |
|
|
14,466 |
|
|
32,355 |
|
|
30,855 |
|
Other |
57,054 |
|
|
40,673 |
|
|
109,746 |
|
|
84,371 |
|
|
$ |
108,978 |
|
|
$ |
87,286 |
|
|
$ |
211,399 |
|
|
$ |
183,212 |
|
|
Schedule of revenue generated by each of the Company's product lines |
Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
2021 |
|
2020 |
|
2021 |
|
2020 |
Asia |
|
|
|
|
|
|
|
General health |
$ |
12,698 |
|
|
$ |
8,263 |
|
|
$ |
23,990 |
|
|
$ |
17,309 |
|
Immune |
382 |
|
|
179 |
|
|
585 |
|
|
380 |
|
Cardiovascular |
12,260 |
|
|
9,323 |
|
|
22,163 |
|
|
18,662 |
|
Digestive |
7,747 |
|
|
8,391 |
|
|
14,618 |
|
|
14,547 |
|
Personal care |
5,290 |
|
|
1,877 |
|
|
7,814 |
|
|
4,882 |
|
Weight management |
5,159 |
|
|
4,724 |
|
|
10,121 |
|
|
7,935 |
|
|
43,536 |
|
|
32,757 |
|
|
79,291 |
|
|
63,715 |
|
Europe |
|
|
|
|
|
|
|
General health |
$ |
9,667 |
|
|
$ |
6,816 |
|
|
$ |
19,139 |
|
|
$ |
14,776 |
|
Immune |
1,818 |
|
|
1,370 |
|
|
3,834 |
|
|
3,814 |
|
Cardiovascular |
2,836 |
|
|
2,215 |
|
|
5,828 |
|
|
5,112 |
|
Digestive |
5,567 |
|
|
3,781 |
|
|
11,107 |
|
|
8,713 |
|
Personal care |
999 |
|
|
718 |
|
|
2,425 |
|
|
2,469 |
|
Weight management |
568 |
|
|
565 |
|
|
1,322 |
|
|
1,208 |
|
|
21,455 |
|
|
15,465 |
|
|
43,655 |
|
|
36,092 |
|
North America |
|
|
|
|
|
|
|
General health |
$ |
16,349 |
|
|
$ |
14,887 |
|
|
$ |
32,619 |
|
|
$ |
30,351 |
|
Immune |
4,101 |
|
|
5,049 |
|
|
8,975 |
|
|
12,847 |
|
Cardiovascular |
4,010 |
|
|
3,679 |
|
|
8,235 |
|
|
7,846 |
|
Digestive |
10,016 |
|
|
7,858 |
|
|
19,479 |
|
|
16,099 |
|
Personal care |
1,834 |
|
|
1,975 |
|
|
3,653 |
|
|
3,904 |
|
Weight management |
1,062 |
|
|
1,023 |
|
|
2,173 |
|
|
2,181 |
|
|
37,372 |
|
|
34,471 |
|
|
75,134 |
|
|
73,228 |
|
Latin America and Other |
|
|
|
|
|
|
|
General health |
$ |
1,873 |
|
|
$ |
1,350 |
|
|
$ |
3,848 |
|
|
$ |
2,964 |
|
Immune |
697 |
|
|
380 |
|
|
1,508 |
|
|
1,489 |
|
Cardiovascular |
425 |
|
|
263 |
|
|
903 |
|
|
641 |
|
Digestive |
3,001 |
|
|
2,264 |
|
|
5,872 |
|
|
4,326 |
|
Personal care |
398 |
|
|
212 |
|
|
743 |
|
|
464 |
|
Weight management |
221 |
|
|
124 |
|
|
445 |
|
|
293 |
|
|
6,615 |
|
|
4,593 |
|
|
13,319 |
|
|
10,177 |
|
|
$ |
108,978 |
|
|
$ |
87,286 |
|
|
$ |
211,399 |
|
|
$ |
183,212 |
|
|
Schedule of consolidated property, plant and equipment by geographical locations |
From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2021 |
|
December 31, 2020 |
Property, plant and equipment: |
|
|
|
United States |
$ |
48,396 |
|
|
$ |
50,025 |
|
Other |
3,795 |
|
|
4,330 |
|
Total property, plant and equipment, net |
$ |
52,191 |
|
|
$ |
54,355 |
|
|
Schedule of assets per segment |
Total assets per segment is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2021 |
|
December 31, 2020 |
Assets: |
|
|
|
Asia |
$ |
89,245 |
|
|
$ |
82,572 |
|
Europe |
18,453 |
|
|
16,398 |
|
North America |
116,074 |
|
|
142,324 |
|
Latin America and Other |
9,418 |
|
|
8,204 |
|
Total assets |
$ |
233,190 |
|
|
$ |
249,498 |
|
|